Impact of CBCT Frequency on Target Coverage and Dose to the Organs at Risk in Adjuvant Breast Cancer Radiotherapy

Overview

Journal Sci Rep

Specialty Science

Date 2021 Aug 31

PMID 34462489

Citations 4

Authors

Kai J Borm

Yannis Junker

Mathias Dusberg

Michal Devecka

Stefan Munch

Hendrik Dapper

Markus Oechsner

Stephanie E Combs

Affiliations

Soon will be listed here.

Abstract

The current study aims to assess the effect of cone beam computed tomography (CBCT) frequency during adjuvant breast cancer radiotherapy with simultaneous integrated boost (SIB) on target volume coverage and dose to the organs at risk (OAR). 50 breast cancer patients receiving either non-hypofractionated or hypofractionated radiotherapy after lumpectomy including a SIB to the tumor bed were selected for this study. All patients were treated in volumetric modulated arc therapy (VMAT) technique and underwent daily CBCT imaging. In order to estimate the delivered dose during the treatment, the applied fraction doses were recalculated on daily CBCT scans and accumulated using deformable image registration. Based on a total of 2440 dose recalculations, dose coverage in the clinical target volumes (CTV) and OAR was compared depending on the CBCT frequency. The estimated delivered dose (V95%) for breast-CTV and SIB-CTV was significantly lower than the planned dose distribution, irrespective of the CBCT-frequency. Between daily CBCT and CBCT on alternate days, no significant dose differences were found regarding V95% for both, breast-CTV and SIB-CTV. Dose distribution in the OAR was similar for both imaging protocols. Weekly CBCT though led to a significant decrease in dose coverage compared to daily CBCT and a small but significant dose increase in most OAR. Daily CBCT imaging might not be necessary to ensure adequate dose coverage in the target volumes while efficiently sparing the OAR during adjuvant breast cancer radiotherapy with SIB.

Citing Articles

A novel comprehensive metric balancing imaging dose and setup accuracy in image-guided radiotherapy: concept proposal and clinical validation.

Liu J, Fu X, Luo Z, Yin C, Li Q, Fan X Front Oncol. 2024; 14:1463219.

PMID: 39655072 PMC: 11625807. DOI: 10.3389/fonc.2024.1463219.

Evaluation of dose delivery based on deformed CT using a commercial software for lung cancer.

Chen J, Chen K, Ouyang M, Wang G, Bai P, You H Sci Rep. 2024; 14(1):14470.

PMID: 38914766 PMC: 11196743. DOI: 10.1038/s41598-024-65381-x.

ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation.

Mast M, Leong A, Korreman S, Lee G, Probst H, Scherer P Tech Innov Patient Support Radiat Oncol. 2023; 28:100219.

PMID: 37745181 PMC: 10511493. DOI: 10.1016/j.tipsro.2023.100219.

As Easy as 1, 2, 3? How to Determine CBCT Frequency in Adjuvant Breast Radiotherapy.

Junker Y, Dusberg M, Asadpour R, Klusen S, Munch S, Bernhardt D Cancers (Basel). 2022; 14(17).

PMID: 36077701 PMC: 9454766. DOI: 10.3390/cancers14174164.

References

Krug D, Vonthein R, Schreiber A, Boicev A, Zimmer J, Laubach R . Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial. Strahlenther Onkol. 2020; 197(9):802-811. PMC: 8397631. DOI: 10.1007/s00066-020-01730-9. View

Lin J, Tsai J, Chou Y, Li M, Liu W . Compared with intensity-modulated radiotherapy, image-guided radiotherapy reduces severity of acute radiation-induced skin toxicity during radiotherapy in patients with breast cancer. Cancer Med. 2018; 7(8):3622-3629. PMC: 6089195. DOI: 10.1002/cam4.1630. View

Sa A, Fermento A, Neves D, Ferreira S, Silva T, Coelho C . Radiotherapy setup displacements in breast cancer patients: 3D surface imaging experience. Rep Pract Oncol Radiother. 2018; 23(1):61-67. PMC: 5773710. DOI: 10.1016/j.rpor.2017.12.007. View

Offersen B, Boersma L, Kirkove C, Hol S, Aznar M, Sola A . ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol. 2016; 118(1):205-8. DOI: 10.1016/j.radonc.2015.12.027. View

Whelan T, Julian J, Berrang T, Kim D, Germain I, Nichol A . External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019; 394(10215):2165-2172. DOI: 10.1016/S0140-6736(19)32515-2. View

Lemanski C, Thariat J, Ampil F, Bose S, Vock J, Davis R . Image-guided radiotherapy for cardiac sparing in patients with left-sided breast cancer. Front Oncol. 2014; 4:257. PMC: 4172060. DOI: 10.3389/fonc.2014.00257. View

Borm K, Voppichler J, Dusberg M, Oechsner M, Vag T, Weber W . FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients. Int J Radiat Oncol Biol Phys. 2018; 103(3):574-582. DOI: 10.1016/j.ijrobp.2018.07.2025. View

Kim D, Chung W, Yoon M . Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy. Health Phys. 2013; 104(5):499-503. DOI: 10.1097/HP.0b013e318285c685. View

Cole A, Veiga C, Johnson U, DSouza D, Lalli N, McClelland J . Toward adaptive radiotherapy for lung patients: feasibility study on deforming planning CT to CBCT to assess the impact of anatomical changes on dosimetry. Phys Med Biol. 2018; 63(15):155014. PMC: 6329444. DOI: 10.1088/1361-6560/aad1bb. View

10.

Yang Y, Schreibmann E, Li T, Wang C, Xing L . Evaluation of on-board kV cone beam CT (CBCT)-based dose calculation. Phys Med Biol. 2007; 52(3):685-705. DOI: 10.1088/0031-9155/52/3/011. View

11.

Doi Y, Nakao M, Miura H, Ozawa S, Kenjo M, Nagata Y . Hybrid volumetric-modulated arc therapy for postoperative breast cancer including regional lymph nodes: the advantage of dosimetric data and safety of toxicities. J Radiat Res. 2020; 61(5):747-754. PMC: 7482153. DOI: 10.1093/jrr/rraa057. View

12.

Donovan E, Castellano I, Eagle S, Harris E . Clinical implementation of kilovoltage cone beam CT for the verification of sequential and integrated photon boost treatments for breast cancer patients. Br J Radiol. 2012; 85(1019):e1051-7. PMC: 3477491. DOI: 10.1259/bjr/28845176. View

13.

Batumalai V, Phan P, Choong C, Holloway L, Delaney G . Comparison of setup accuracy of three different image assessment methods for tangential breast radiotherapy. J Med Radiat Sci. 2016; 63(4):224-231. PMC: 5167282. DOI: 10.1002/jmrs.180. View

14.

Alaei P, Spezi E . Imaging dose from cone beam computed tomography in radiation therapy. Phys Med. 2015; 31(7):647-58. DOI: 10.1016/j.ejmp.2015.06.003. View

15.

Luh J, Albuquerque K, Cheng C, Ermoian R, Nabavizadeh N, Parsai H . ACR-ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT). Am J Clin Oncol. 2020; 43(7):459-468. DOI: 10.1097/COC.0000000000000697. View

16.

Basaula D, Quinn A, Walker A, Batumalai V, Kumar S, Delaney G . Risks and benefits of reducing target volume margins in breast tangent radiotherapy. Australas Phys Eng Sci Med. 2017; 40(2):305-315. DOI: 10.1007/s13246-017-0529-3. View

17.

Topolnjak R, Sonke J, Nijkamp J, Rasch C, Minkema D, Remeijer P . Breast patient setup error assessment: comparison of electronic portal image devices and cone-beam computed tomography matching results. Int J Radiat Oncol Biol Phys. 2010; 78(4):1235-43. DOI: 10.1016/j.ijrobp.2009.12.021. View

18.

Borm K, Kessel K, Devecka M, Muench S, Straube C, Schiller K . Variability in lymph node irradiation in patients with breast cancer-results from a multi-center survey in German-speaking countries. Strahlenther Onkol. 2019; 196(1):15-22. DOI: 10.1007/s00066-019-01537-3. View

19.

De Rose F, Fogliata A, Franceschini D, Iftode C, Navarria P, Comito T . Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature. Breast. 2018; 42:31-37. DOI: 10.1016/j.breast.2018.08.098. View

20.

Batumalai V, Holloway L, Delaney G . A review of setup error in supine breast radiotherapy using cone-beam computed tomography. Med Dosim. 2016; 41(3):225-9. DOI: 10.1016/j.meddos.2016.05.001. View